Compare VNET & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNET | IRMD |
|---|---|---|
| Founded | 1999 | 1992 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2011 | 2014 |
| Metric | VNET | IRMD |
|---|---|---|
| Price | $3.49 | $83.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | $12.72 | ★ $118.00 |
| AVG Volume (30 Days) | ★ 5.6M | 84.7K |
| Earning Date | 11-19-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 0.86 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | $17.17 | $9.85 |
| Revenue Next Year | $22.38 | $13.07 |
| P/E Ratio | ★ N/A | $97.44 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $3.52 | $76.45 |
| 52 Week High | $14.48 | $107.90 |
| Indicator | VNET | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 27.82 | 45.33 |
| Support Level | N/A | $85.00 |
| Resistance Level | $6.93 | $88.59 |
| Average True Range (ATR) | 0.33 | 1.82 |
| MACD | -0.03 | -0.45 |
| Stochastic Oscillator | 1.00 | 24.57 |
VNET started as AsiaCloud in 1999 and moved into the data center business, opening its first self-developed data center in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of June 2026, it had 50,081 retail cabinets, with the majority in Beijing, Shanghai, and the Greater Bay Area. It also had 1.007 megawatts of wholesale capacity in service, with a further 585 MW under construction and a further 1.050 MW held for future development.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.